Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Benzyl isothiocyanate (BITC) is a naturally occurring isothiocyanate compound found in cruciferous vegetables such as broccoli, cabbage, and watercress. It has demonstrated antibacterial properties and notable anticancer activities in preclinical studies. Mechanistically, BITC exerts its effects by modulating various cellular signaling pathways involved in apoptosis, cell proliferation inhibition, cell cycle arrest, metastasis suppression, angiogenesis inhibition, and autophagy induction. In bacteria such as *Campylobacter jejuni*, BITC disrupts major metabolic processes by targeting proteins—leading to protein aggregation and impaired energy metabolism—which ultimately results in cell death. In animal models and cellular systems it has shown chemopreventive potential against several cancers and may also have beneficial effects on obesity-related metabolic disorders[1][3][5][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on benzyl isothiocyanate.